Drug Maker Secures Patent on THC and CBD as Cancer Treatment
A pharmaceutical company in the United Kingdom, specializing in the research and development of pot-based drugs, recently obtained early approval on a patent covering two specific cannabinoids found in marijuana to be used as treatment for brain cancer.
According to a press release, GW Pharmaceuticals will hold the patent rights to the two primary compounds found in marijuana, THC and CBD, for use as medicine for patients suffering from gliomas — the most common form of malignant brain tumor. Read more
Latest posts by Stephen Carter (see all)
- Central Texas Candidate for Congress Takes Bold Stance on Marijuana Policy - September 17, 2017